» Articles » PMID: 8958977

Cytokine Gene Therapy of Cancer Using Interleukin-12: Murine and Clinical Trials

Overview
Specialty Science
Date 1996 Oct 31
PMID 8958977
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents.

Obermajer N, Urban J, Wieckowski E, Muthuswamy R, Ravindranathan R, Bartlett D Nat Protoc. 2018; 13(2):335-357.

PMID: 29345636 DOI: 10.1038/nprot.2017.130.


Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.

Oh E, Choi I, Hong J, Yun C Oncotarget. 2016; 8(3):4730-4746.

PMID: 28002796 PMC: 5354867. DOI: 10.18632/oncotarget.13972.


Internal ribosome entry site-based vectors for combined gene therapy.

Renaud-Gabardos E, Hantelys F, Morfoisse F, Chaufour X, Garmy-Susini B, Prats A World J Exp Med. 2015; 5(1):11-20.

PMID: 25699230 PMC: 4308528. DOI: 10.5493/wjem.v5.i1.11.


Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency.

Mendez N, Herrera V, Zhang L, Hedjran F, Feuer R, Blair S Biomaterials. 2014; 35(35):9554-61.

PMID: 25154663 PMC: 4157089. DOI: 10.1016/j.biomaterials.2014.08.010.


Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

Huang J, Zhang S, Choi K, Choi I, Kim J, Lee M Mol Ther. 2009; 18(2):264-74.

PMID: 19738604 PMC: 2839296. DOI: 10.1038/mt.2009.205.